BridgeBio Pharma, Inc. financial data

Symbol
BBIO on Nasdaq
Location
Palo Alto, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 29 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 453% % 9.1%
Quick Ratio 6.7% %
Debt-to-equity -156% % 2%
Operating Margin -172% % 31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 192,708,813 shares 2%
Common Stock, Shares, Outstanding 192,633,286 shares 1.9%
Entity Public Float $3,729,400,000 USD 80%
Common Stock, Value, Issued $200,000 USD 2.6%
Weighted Average Number of Shares Outstanding, Basic 191,854,152 shares 1.8%
Weighted Average Number of Shares Outstanding, Diluted 191,854,152 shares 1.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $353,780,000 USD 62%
Cost of Revenue $14,939,000 USD 525%
Research and Development Expense $465,886,000 USD -8%
Costs and Expenses $963,656,000 USD 26%
Operating Income (Loss) $609,876,000 USD -12%
Nonoperating Income (Expense) $194,108,000 USD -298%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $186,482,000 USD -14%
Income Tax Expense (Benefit) $1,708,000 USD
Earnings Per Share, Basic -4 USD/shares -74%
Earnings Per Share, Diluted -4 USD/shares -74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $642,951,000 USD 141%
Marketable Securities, Current $7,939,000 USD -80%
Accounts Receivable, after Allowance for Credit Loss, Current $116,518,000 USD
Inventory, Net $24,527,000 USD
Assets, Current $839,382,000 USD 89%
Property, Plant and Equipment, Net $5,830,000 USD -33%
Operating Lease, Right-of-Use Asset $6,553,000 USD 1.8%
Intangible Assets, Net (Excluding Goodwill) $28,795,000 USD 17%
Other Assets, Noncurrent $25,522,000 USD 26%
Assets $998,250,000 USD 50%
Accounts Payable, Current $18,702,000 USD 40%
Employee-related Liabilities, Current $56,155,000 USD 29%
Contract with Customer, Liability, Current $9,087,000 USD
Liabilities, Current $216,600,000 USD 56%
Contract with Customer, Liability, Noncurrent $13,131,000 USD
Operating Lease, Liability, Noncurrent $3,427,000 USD -41%
Other Liabilities, Noncurrent $679,000 USD 80%
Liabilities $2,920,979,000 USD 55%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,000 USD -60%
Retained Earnings (Accumulated Deficit) $3,628,331,000 USD -28%
Stockholders' Equity Attributable to Parent $1,933,070,000 USD -57%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1,922,752,000 USD -58%
Liabilities and Equity $998,250,000 USD 50%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $199,235,000 USD 9.2%
Net Cash Provided by (Used in) Financing Activities $60,328,000 USD -78%
Net Cash Provided by (Used in) Investing Activities $1,595,000 USD -107%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 200,230,458 shares 2.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $140,502,000 USD -270%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $645,096,000 USD 58%
Interest Paid, Excluding Capitalized Interest, Operating Activities $23,271,000 USD -34%
Deferred Tax Assets, Valuation Allowance $727,326,000 USD 8.2%
Deferred Tax Assets, Gross $728,638,000 USD 7.4%
Operating Lease, Liability $8,721,000 USD -16%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $797,121,000 USD -82%
Lessee, Operating Lease, Liability, to be Paid $9,466,000 USD -18%
Operating Lease, Liability, Current $5,294,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $582,000 USD -74%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,375,000 USD 5.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $745,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year Three $454,000 USD -2.2%
Deferred Tax Assets, Operating Loss Carryforwards $379,019,000 USD 5.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $36,866,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $487,000 USD 5%
Operating Lease, Payments $1,470,000 USD -7.8%
Additional Paid in Capital $2,018,335,000 USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,600,000 USD 8.3%
Depreciation, Depletion and Amortization $1,284,000 USD -20%
Deferred Tax Assets, Net of Valuation Allowance $1,312,000 USD -80%
Share-based Payment Arrangement, Expense $138,427,000 USD 21%
Interest Expense $86,982,000 USD 8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%